CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
109.000 |
Evidence |
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
IL10RA |
IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor |
109.000 |
Evidence |
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
109.000 |
Evidence |
O
|
HCK |
IPI00029769 |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
109.000 |
Evidence |
|
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
109.000 |
Evidence |
|
C4BPA |
C4BPA, C4BP: C4b-binding protein alpha chain precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
109.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
IL10RA |
IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor |
109.000 |
Evidence |
|
HCK |
IPI00029769 |
CAP1 |
CAP1, CAP: Adenylyl cyclase-associated protein 1 |
108.000 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
KNG1 |
IPI00215894 |
108.000 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
KNG1 |
IPI00215894 |
108.000 |
Evidence |
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
LYN |
LYN: Tyrosine-protein kinase Lyn |
108.000 |
Evidence |
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
JAK1 |
|
108.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
107.000 |
Evidence |
|
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
C1orf82 |
RPAP2, C1orf82: RNA polymerase II-associated protein 2 |
107.000 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
107.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
107.000 |
Evidence |
O
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
BMX |
IPI00514142 |
107.000 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
JAK1 |
|
106.000 |
Evidence |
O
|
HIST1H2BO |
HIST1H2BO, H2BFH, H2BFN: Histone H2B type 1-O |
HIST1H2BD |
HIST1H2BD, H2BFB, HIRIP2: Histone H2B type 1-D |
106.000 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
JAK1 |
|
106.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
STAT3 |
|
106.000 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|